Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Medical Diagnostic Kit Supply and Assembly

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract entails the supply, assembly, packaging, and delivery of Wright Giemsa Staining Kits designated by NSN 6550-01-449-4553, specifically for use in malaria diagnosis. All kits must meet stringent FDA and military standards to ensure diagnostic accuracy and reliability in operational environments. The work is to be performed under a subcontract arrangement with a strict submission deadline of August 3, 2026, following a posting date of July 28, 2026. The North American Industry Classification System code 325412 applies, indicating the involvement of pharmaceutical and medicinal product manufacturing. The kits are to be delivered to APO, 09227-0000, reflecting their intended use in military medical supply chains. This procurement is managed by the Department of Defense under the Medical Supply Chain MD Surg FSF organization, emphasizing the critical nature of these diagnostic tools for frontline personnel.

General Info

Supply and delivery of FDA-compliant Wright Giemsa kits for malaria diagnosis to military APO, meeting DoD standards by August 3, 2026.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSFView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

APO, AE, 09227-0000, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSF
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSF
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply, assembly, packaging, and delivery of Wright Giemsa Staining Kits (NSN: 6550-01-449-4553) for malaria diagnosis, compliant with FDA and military standards.

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
TRICHLOROACETIC ACID
Solicitation # SPE2DP-26-T-4354
The contract specifies the procurement of Trichloroacetic Acid, ACS grade, 80% concentration, in 15 mL units, identified by NSN 6505-01-363-7674 and part number 749887 from AmerisourceBergen Drug Corp. The item is classified as a TYPE I (CODE M) with a non-extendable shelf life of 24 months and must be packaged and marked in full compliance with Medical Marking Standard No. 1, superseding MIL-STD-129. Packaging must meet commercial standards with sealed unit containers and shipping containers capable of preventing damage during transit, ensuring safe delivery by common carrier at the lowest cost to the designated destination in APO, 09094-3219. The item is regulated by the FDA, requiring referral through EBS for confirmation, and delivery must occur within 20 days FOB destination with zero quantity variance allowed. Inspection and acceptance occur at the delivery point. Suppliers must provide Safety Data Sheets (SDS) and labels compliant with OSHA’s revised Hazard Communication Standard (29 C.F.R. 1910.1200), effective June 1, 2015, and must train employees on these requirements. All documentation must align with DLA’s Master List of Technical and Quality Requirements, and the unit of issue is BT, equivalent to 15 mL. The contract is issued under SPE2DP-26-T-4354, with a response deadline of August 4, 2026, and is governed by federal procurement regulations including DLA packaging and hazardous material handling standards.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
DIBUCAINE OINTMENT
Solicitation # SPE2DP-26-T-4358
Dibucaine Ointment USP is a topical pharmaceutical product containing one percent dibucaine as the active ingredient, specifically formulated for rectal administration and external use only. It is supplied in a collapsible tube and a rectal applicator, with each unit of issue being a single package containing one ounce or 28 grams of the ointment. Storage requirements mandate a temperature range of 15 to 30 degrees Celsius (59 to 86 degrees Fahrenheit). The product is regulated by the FDA and must be marked in accordance with the latest edition of Medical Marking Standard No. 1, with a non-extendable shelf life of 36 months as a Type I (Code Q) item. Packaging must comply with MIL-STD-2073-1E, and government identification must be removed from any non-accepted supplies. The contract specifies a procurement quantity of two packages, to be delivered FOB destination within 20 days, with zero variance allowed in quantity. The item is identified by NSN 6505002999535 and NDC 00536-1211-95, supplied by The Harvard Drug Group, L.L.C. The solicitation number is SPE2DP-26-T-4358, with a response deadline of August 4, 2026, and the place of performance is Nellis AFB, NV. The contract includes adherence to DLA’s Master List of Technical and Quality Requirements, and buyers must submit referrals in EBS to confirm product compliance prior to award.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
ALBUTEROL SULFATE INHA
Solicitation # SPE2DP-26-T-4353
Albuterol Sulfate Inhalation Aerosol with HFA is a prescription-only medication for oral inhalation, delivering 108 micrograms of albuterol sulfate per actuation, equivalent to 90 micrograms of albuterol base, supplied in an 8.5-gram canister containing 200 metered doses. The product must be stored at room temperature between 59°F and 77°F (15°C and 25°C), protected from extreme heat or cold, with specific warnings against puncturing, exposing to temperatures above 120°F, or spraying into the eyes. It has a non-extendable shelf life of 24 months and is classified as a TYPE I (CODE M) item under the Federal supply system. Labeling must include the National Stock Number, manufacturer date, expiration or retest date, contract number, and lot number, in compliance with the Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must meet commercial standards, with each unit sealed in a protective container and shipped in suitable exterior packaging to ensure safe delivery via common carrier. The product is regulated by the FDA and subject to Hazard Communication Standard requirements, mandating submission of Safety Data Sheets and compliant HCS labels aligned with 29 C.F.R. 1910.1200 prior to award, along with employee training on updated chemical labeling protocols. The contract specifies delivery of three units FOB destination within 20 days, with no variance allowed in quantity, and inspection and acceptance occurring at the delivery point. The NSN is 6505-01-543-6562, and the solicitation details identify Teva Pharmaceuticals USA, Inc. and Perrigo Direct Inc. as potential suppliers under procurement number SPE2DP-26-T-4353.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
VECURONIUM BROMIDE FOR
Solicitation # SPE2DP-26-T-4359
Vecuronium Bromide for Injection is a freeze-dried powder containing 10 mg of the active ingredient, supplied in packages of ten vials each, with a total shelf life of 24 months. At the time of receipt by the first government activity, the product must have a minimum of 21 months of remaining shelf life. The powder must be stored at controlled room temperature between 20 to 25°C (68 to 77°F) and protected from light, with containers retained in their outer cartons until use. Packaging and labeling must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all units must be sealed and packaged in commercial shipping containers that ensure safe delivery via common carrier at the lowest rate. The product is not considered hazardous under FED-STD-313 and must be packaged in accordance with ASTM D3951, though DLA’s Master List of Technical and Quality Requirements takes precedence. Shipments must be sent by traceable means only; parcel post is prohibited. Deliveries are FOB destination with zero variance allowed, and inspection and acceptance occur upon arrival. The supplier is Hikma Pharmaceuticals USA Inc., with NDC 00143-9234-10, and the contract requires multiple deliveries across different locations and dates in July 2026, totaling eight line items for one or three packages per delivery. All packaging, palletization, and labeling must adhere to DLA Packaging Requirements for Procurement and specific storage and handling instructions.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
PETROLATUM, WHITE
Solicitation # SPE2DP-26-T-4355
The contract specifies the procurement of 8 units (TU) of white petrolatum, USP, with each TU equaling 28 milligrams, for a total quantity of 224 milligrams. The material must comply with stringent packaging and marking requirements per the Medical Marking Standard No. 1, replacing all references to MIL-STD-129, and must be packaged in sealed commercial unit containers that protect against damage, with exterior shipping containers ensuring safe, cost-effective delivery to the destination. The item is classified as a TYPE I (CODE Q) with a non-extendable shelf life of 36 months and must be shipped by the fastest traceable means, excluding parcel post. Delivery is required within five days of award under FOB destination terms with zero quantity variance permitted and acceptance occurring at the delivery point. The product must be commercially packaged per ASTM D3951 unless deemed hazardous under FED-STD-313, in which case TQ requirement IP025 applies; however, all DLA Master List of Technical and Quality Requirements override any conflicting standards. Packaging and labeling must reflect the specified unit of issue and quantity per unit pack, and palletization must adhere to DLA packaging guidelines. The delivery address is for the 0182 IN BN 01 HHC INFANTRY BN in Melrose, MA, with the required delivery date set for July 30, 2026, and the contract reference number is SPE2DP-26-T-4355.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
TYPHOID VI POLYSACCHAR
Solicitation # SPE2DP-26-T-4363
The contract specifies the procurement of Typhoid Vi Polysaccharide Vaccine, a modified acellular vaccine supplied in 10 mL vials, with a total quantity of 10 vials, each containing 20 doses. The vaccine must adhere to the Medical Procurement Item Description (MPID) No. 3 dated 20 March 2006, with modifications including the substitution of “vial” for “box” in packaging references. The product must have a minimum shelf life of 18 months, with at least 15 months remaining at the time of delivery to the first government activity, and this shelf-life requirement is non-extendable. The vaccine requires constant refrigeration between 2 and 8 degrees Celsius (36 to 46 degrees Fahrenheit) throughout transport and storage, and all packaging, labeling, and marking must comply with the latest edition of the Medical Marking Standard No. 1 and MIL-STD-129. Commercial packaging must conform to ASTM D3951 unless overridden by DLA’s Master List of Technical and Quality Requirements, which take precedence. The product is to be delivered FOB destination within five days of the contract award, with no variance allowed in quantity. Delivery is directed to USS RALPH JOHNSON DDG 114 at FPO AP 96691-3300, with transportation governed by DLAD procedure notes C19 and C20. The contract is tied to NSN 6505-01-385-6328 and solicitation SPE2DP-26-T-4363, with an original required delivery date of 31 July 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
SUMATRIPTAN SUCCINA
Solicitation # SPE2DP-26-T-4365
Sumatriptan succinate tablets, 25 mg film-coated, are provided in bottles of nine tablets for the acute treatment of migraine with or without aura in adults and must be stored at controlled room temperature between 20 to 25 °C (68 to 77 °F) with protection from light. The contract specifies adherence to strict packaging and marking standards including MIL-STD-2073-1E and MIL-STD-129, with palletization following DLA packaging requirements and shelf life constrained to 24 months under Type I (Code M) non-extendable limits. Deliveries are scheduled for multiple military installations across Fort Bliss, Fort Hood, and Fort Bragg with firm delivery windows of 20 days and no variance allowed in quantity. Each shipment must be transported via traceable means excluding parcel post, with inspection and acceptance occurring at the destination. The contract includes multiple line items under solicitation SPE2DP-26-T-4365, totaling 54 units (nine-tablet bottles), with delivery dates ranging from April to July 2026, and all items carry the same NSN 6505017246289. The supplier must comply with technical and quality requirements referenced from the DLA Master List, and all labeling and documentation must conform to the Medical Marking Standard No. 1 and government-specific identifiers. Contract performance is tracked through detailed logistics codes, tracking numbers, and government-specific identifiers for procurement, distribution, and accountability.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSF

Same awarding agency

NAICS: 339112
New
DIBBS
STETHOSCOPE
Solicitation # SPE2DS-26-T-283Z
The contract specifies the procurement of a STETHOSCOPE SYNERGY DUAL-FREQUENCY, DUAL HEAD model featuring a bell-diaphragm design with a floating diaphragm and plastic construction. It includes a long black tube connecting the chest piece to the aural tubes, a pair of snap-on polyurethane rims for both the diaphragm and bell, and one pair of eartips. The unit must be packaged in a sealed container capable of protecting it from damage or breakage, and shipped in commercial exterior containers suitable for secure delivery via common carrier at the lowest possible rate to the designated point of delivery. All items must be marked in accordance with Medical Marking Standard No. 1, which replaces MIL-STD-129, and suppliers must ensure compliance by accessing the current standard via the DLA Troop Support website. The unit of issue is each, and the item is identified by NSN 6515-01-314-6694 with a quantity of one unit per order and a total demand of two units. Bidders are required to provide the source and part number being supplied. The solicitation number is SPE2DS-26-T-283Z, with a response deadline of August 4, 2026, and delivery must occur within 20 days of award. The procurement falls under NAICS code 339112 and is administered by the Department of Defense through the Medical Supply Chain MD Surg FSF, with delivery to APO 09094-3219. Technical and quality requirements referenced in the DLA Master List must be followed, with the applicable revision determined by the solicitation issue date or amendment date for large acquisitions.
Surgical and Medical Instrument Manufacturing

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 339112
New
DIBBS
BRACE, ANKLE
Solicitation # SPE2DS-26-T-283M
The contract is for the procurement of ankle braces under NSN 6515-01-699-6619, with a quantity of three units to be delivered within 20 days to Blount Island Command in Jacksonville, Florida. The item is regulated by the FDA as a Class I medical device, requiring compliance with registration, listing, labeling, and GMP requirements even if a 510(k) is not needed. All packaging and marking must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and packaging must meet DLA’s commercial standards, ensuring protection during transit and safe delivery via traceable freight methods—parcel post is explicitly prohibited. The delivery is FOB destination, with inspection and acceptance occurring at the delivery point, and no variance in quantity is permitted. Technical and quality requirements referenced by R or I numbers are governed by the DLA Master List of Technical and Quality Requirements, with the applicable revision tied to the solicitation or award date depending on acquisition size. The contract mandates compliance with DLA packaging and palletization standards, and all documentation must align with the specified unit of issue and Federal supply system codes. The contracting activity is the Department of Defense’s Medical Supply Chain, and the solicitation number is SPE2DS-26-T-283M with a response deadline in August 2026.
Surgical and Medical Instrument Manufacturing

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 339112
New
DIBBS
TUBE, TRACHEAL
Solicitation # SPE2DS-26-T-284P
The contract specifies the procurement of endotracheal tubes, 9mm, plastic, sterile, designated by NSN 6515-01-501-6090, with a quantity of two units. These tubes are designed for use in nasal and oral anatomy, featuring a high-volume, large-diameter cuff that ensures an effective seal while minimizing contact with the tracheal wall and reducing capillary restriction through a low-pressure design. The tapered cuff facilitates easier insertion and lowers the risk of herniation, making them suitable for both short- and long-term ventilation as well as routine surgical procedures. Each tube is individually packaged and available with a Murphy eye only. The items must comply with DLA packaging requirements and technical quality standards outlined in the DLA Master List of Technical and Quality Requirements, with the applicable revision determined by the solicitation or award date. Bidders are required to specify the source and part number being supplied. The solicitation, identified as SPE2DS-26-T-284P, was posted on July 29, 2026, with a response deadline of August 4, 2026. The purchase request number is 7017267889, and delivery is required within 20 days of award. The contract falls under NAICS code 339112 and is managed by the Department of Defense through the Medical Supply Chain MD Surg FSF. The place of performance is Raleigh, North Carolina, with a zip code of 27607-0000. Primary point of contact for the solicitation is Colin Owens, reachable via email at colin.owens@dla.mil or phone at 4457375800. The contract is part of a federal procurement process and requires adherence to all DLA technical and quality specifications without exception.
Surgical and Medical Instrument Manufacturing

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 339113
New
DIBBS
CONTROL, GLUCOSE
Solicitation # SPE2DS-26-T-283Y
The contract specifies the procurement of Prodigy Glucose Control Solution, Low Level 1, in 4 mL units, compatible with all Prodigy brand glucose meters and intended solely for in vitro diagnostic use. The product must have a guaranteed shelf life of 24 months, with no more than three months elapsed from the date of manufacture to the date of delivery to the government. Storage must be at room temperature and freezing is strictly prohibited. The solution is regulated by the FDA and must be sourced from approved manufacturers, specifically Prodigy Diabetes Care LLC or Cardinal Health 200, LLC, with their designated part numbers. All packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and adhere strictly to DLA’s Packaging Requirements for Procurement, with commercial packaging in accordance with ASTM D3951 unless otherwise overridden by DLA's technical requirements. The unit of issue is each, and packaging must protect against damage and ensure safe transport via common carriers at the lowest possible rate. The contract includes two line items totaling two units, each priced at $2.00 and $4.00 respectively, with firm fixed prices and zero tolerance for quantity variance. Delivery is required within five days of order placement, FOB destination, with inspection and acceptance occurring at the point of delivery. Shipments must use the fastest traceable means and are prohibited from using parcel post. Two distinct delivery addresses are specified: one at Fort Bragg, North Carolina, and another in Melrose, Massachusetts, each with assigned tracking codes and logistical identifiers. The material is not classified as hazardous per Fed-STD-313 and must be labeled with the appropriate government identification, with strict compliance required for all packaging, marking, and palletization standards. The solicitation number is SPE2DS-26-T-283Y, with a response deadline of August 4, 2026, and required delivery dates set for July 30 and July 31, 2026, depending on the delivery point.
Surgical Appliance and Supplies Manufacturing

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 456199
New
DIBBS
DRESSING, CHEST SEAL WO
Solicitation # SPE2DS-26-T-283J
The chest seal dressing is a specialized medical device designed for rapid deployment in trauma scenarios involving open chest wounds. It features a three-channel pressure relief vent system that prevents air from entering the chest cavity during inhalation while allowing trapped air and blood to escape during exhalation, reducing the risk of tension pneumothorax. The design includes a fail-safe mechanism ensuring functionality even if two of the three vents become obstructed. The dressing utilizes advanced adhesive technology to maintain a secure seal under extreme environmental conditions and is equipped with a large red-tipped pull tab for single-step peel-and-apply application, enabling easy repositioning or venting if needed. It is packaged in a foil pouch with tear-notches, measuring 7.75 inches square when undeployed, and expands to a 6-inch by 6-inch coverage area upon application. Each unit weighs 1.37 ounces and is issued individually. The product must have a shelf life of 60 months with no extensions permitted, and no more than nine months may have elapsed from the manufacturer’s production date to delivery to the government. Labeling must comply with Medical Marking Standard No. 1, including clear indications of the date of manufacture, expiration or retest date, contract number, and lot number. Packaging must meet commercial standards, with each unit sealed in a protective container and shipped in appropriate exterior packaging to ensure safe transit at the lowest feasible cost. All packaging and marking must conform to DLA requirements, superseding older military standards. The item is identified by NSN 6510-01-624-0840, with a purchase request for two units under contract SPE2DS-26-T-283J, requiring delivery within 20 days to Fort Bragg, North Carolina. Bidders must specify their source and part number, and all technical specifications referenced are governed by the DLA Master List of Technical and Quality Requirements.
All Other Health and Personal Care Retailers

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 334511
New
DIBBS
CATHETERIZATION KIT, UR
Solicitation # SPE2DS-26-T-283U
The contract specifies the procurement of a urethral catheterization kit, item NSN 6515016152124, packaged as a unit of issue (PG) containing ten individual kits. Each kit includes a 16 Fr Foley catheter with a 2000 mL anti-reflux valve bag, sterile drape, underpad, specimen container, five prep balls, povidone-iodine solution, gloves, a prefilled 10 cc sterile water syringe, forceps, and a prefilled 10 cc lubricant syringe. The product must have a mandatory 36-month shelf life, with no more than five months elapsed from manufacture to government delivery. All packaging must comply with DLA Packaging Requirements, including sealed unit containers for protection, commercial shipping containers for safe transport at the lowest rate, and precise labeling per Medical Marking Standard No. 1, superseding MIL-STD-129. The kits are regulated by the FDA and require confirmation through EBS referral. Shipments are destined for two locations: USS Delaware (SSN 791) in FPO AE and Fort Bliss, TX, with delivery required within five days and no quantity variance allowed. Delivery is FOB destination, with inspection and acceptance occurring upon arrival. Packaging must adhere to ASTM D3951 only where not overridden by higher-priority DLA technical requirements, and palletization must follow RP001. Freight must be shipped by traceable means, prohibiting parcel post, and markings must include NSN, manufacturer and CAGE codes, manufacture and expiration dates, contract number, and lot number. The contract covers two CLINs, both at $1.00 per unit, with a required delivery date of July 30, 2026.
Search, Detection, Navigation, Guidance, Aeronautical, and Nautical System and Instrument Manufacturing

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 339112
New
DIBBS
WOUND CLOSURE KIT, FACI
Solicitation # SPE2DS-26-T-283P
The Wound Closure Kit, Facial is a sterile, latex-free, disposable tray designed for facial wound closure procedures, containing essential instruments and supplies to facilitate healing by approximating wound edges. The kit includes four gauze sponges, one metal tissue forcep, one curved mosquito hemostat, one fine-point tissue scissors, one polybag with twist tie, one polylined towel, one polylined fenestrated towel, a pack of three iodophor PVP prep swabs, and one alcohol swab. It is packaged and supplied as a case of twenty units, with a mandated shelf life of eighteen months from the date of manufacture, none of which may have expired prior to delivery. No more than two months may have elapsed between the date of manufacture and the date of delivery to the government. The item is governed by specific technical and quality requirements detailed in the DLA Master List of Technical and Quality Requirements, and must comply with DLA packaging standards. The NSN is 6515-01-710-5754, with a purchase request number of 7017656207, and delivery is due within twenty days of award. The solicitation SPE2DS-26-T-283P was posted on July 29, 2026, with responses due by August 4, 2026, and is managed by the Department of Defense’s Medical Supply Chain MD Surg FSF team, with performance designated to APO 09094-3219. Bidders must specify their source and part number, and all supplies must adhere to government identification removal procedures for non-accepted items.
Surgical and Medical Instrument Manufacturing

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details